SNP-based microarrays identify unbalanced chromosomal abnormalities in individuals with unexplained irregular phenotypes such as intellectual disability, dysmorphic features, congenital anomalies and autism. They also identify lengthy contiguous stretches of homozygosity, which may suggest an elevated likelihood for a recessive condition or uniparental disomy inhibiteur de la PDE5 . Related StoriesUtah chemists devise new way to identify DNA damageCWRU awarded two NIH grants to make pathology picture informatics platformNuclear membrane fixes potentially fatal breaks in DNA strandsThe Affymetrix CytoScan HD Array interrogates the entire genome using a lot more than 2.6 million markers for copy-number evaluation and approximately 750,000 SNPs. The platform offers excellent functionality and exceeds current suggestions for specificity, quality and sensitivity over the genome.
ASH releases declaration on FDA activities to ease drug shortages The American Society of Hematology is encouraged by the steps FDA is taking to ease drug shortages that have significantly affected so many patients with hematologic malignancies under our members’ care. The actions announced today are consistent with the Society’s recommendations to FDA, Congress, and the NATIONAL GOVERNMENT to expand the agency’s authority to prevent medication shortages by requiring manufacturers to provide early notification of impending shortages and importing medications in critical supply. Today While ASH applauds the specific actions announced, we also recognize that these methods represent only a portion of a remedy to a much larger problem.